Avid Bioservices Enters into Contract Manufacturing Agreements with New and Existing Customers
July 08, 2019 08:05 ET
|
Avid Bioservices, Inc
Company Signs Top Ten Global Pharmaceutical Company as New Client and Expands Relationship with Existing Biotechnology Company Customer Agreements Include Process Transfer, Process Development and...
Avid Bioservices Reports Financial Results for Quarter and Fiscal Year Ended April 30, 2019 and Recent Developments
June 27, 2019 16:05 ET
|
Avid Bioservices, Inc
-- Achieved Fourth Quarter Revenue of $17.1 Million, an Increase of 146% Compared to Prior Year Quarter -- -- Generated Income From Continuing Operations During the Fourth Quarter of Fiscal 2019 -- ...
Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2019 After Market Close on June 27, 2019
June 24, 2019 08:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., June 24, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve...
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
June 05, 2019 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., June 05, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve...
Avid Bioservices to Participate at BIO International Convention 2019
May 28, 2019 08:05 ET
|
Avid Bioservices, Inc
-- Company to Provide Insight on Key CDMO Industry Topics through Podium Presentation, Panel Discussion and Executive Interview as Part of Convention’s BioProcess International Theater -- --...
Avid Bioservices Reports Financial Results for Third Quarter Fiscal 2019 and Recent Developments
March 11, 2019 16:05 ET
|
Avid Bioservices, Inc
-- Achieved Revenue of $13.8 Million, an Increase of 102%Compared to Prior Year Quarter -- -- Signed Project Expansion Orders with Existing Customers Representing $23.8 Million -- -- Completed...
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
March 06, 2019 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve...
Avid Bioservices Reports Financial Results for Second Quarter Fiscal 2019 and Recent Developments
December 10, 2018 16:05 ET
|
Avid Bioservices, Inc
-- Fiscal 2019 Projected Revenue of $51 to $55 Million Reaffirmed -- -- Signed Project Expansion Orders for $6.3 Million with Current Customers -- -- Successfully Executed Scheduled Broad Scale...
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
December 05, 2018 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Dec. 05, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve...
Avid Bioservices to Exhibit at the 17th Annual Contracting & Outsourcing Conference
September 20, 2018 08:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...